Maxidex (Dexamethasone)

Dexamethasone penetrates ocular tissues and binds to glucocorticoid receptors inside cells. This binding changes gene expression, suppressing the production of inflammatory mediators such as cytokines, prostaglandins and leukotrienes. The result is decreased vascular permeability, reduced leukocyte infiltration and overall dampening of the inflammatory response.

The dosing regimen for Maxidex is determined by the prescribing ophthalmologist based on the severity of the condition, patient age and response to therapy. Typical regimens may involve one to several drops per eye per day, but the exact schedule should always follow the prescriber’s instructions.

Safety data for dexamethasone eye suspension in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will assess individual circumstances before prescribing.

To request Maxidex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Maxidex contains dexamethasone, a potent corticosteroid with a strong anti‑inflammatory profile. Compared with weaker steroids such as prednisolone acetate, dexamethasone often achieves faster symptom control but may carry a higher risk of intra‑ocular pressure elevation. Choice of agent depends on the clinical scenario and physician preference.

Store Maxidex at room temperature, ideally below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from moisture and direct sunlight, and discard any suspension that appears discolored or contains particles.

Maxidex is applied as an ophthalmic suspension. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac. Close the eye gently for a few seconds and avoid blinking excessively to allow proper absorption.

Serious risks include secondary ocular infections, significant elevation of intra‑ocular pressure leading to glaucoma, cataract formation with prolonged use, and rare events such as retinal detachment. Patients should be monitored regularly for visual changes, pain or signs of infection, and report any concerning symptoms promptly.

Maxidex is contraindicated in individuals with known hypersensitivity to dexamethasone or any component of the formulation. It should also be avoided in eyes with active viral infections (e.g., herpes simplex keratitis) unless directed by a specialist, as steroids can exacerbate viral replication.